New Center Accelerates Cancer Diagnosis, Provides Immediate Access
The James Cancer Diagnostic Center opened in June 2020 to give patients expedited access to diagnostic testing for cancer. The center provides immediate access to cancer providers for anyone with a suspected malignancy, which is especially beneficial to people in communities where access to health care is limited. The center offers expert evaluation and access to testing so that a timely and precise cancer diagnosis can be made in a low-risk environment. Patients may self-refer to the center or be referred by a physician, and visits can be virtual or in person. Read More
Ohio State Breaks Ground on New West Campus Ambulatory Building
The OSUCCC – James, the Ohio State Wexner Medical Center and Nationwide Children’s Hospital broke ground for a West Campus Ambulatory Building near the intersection of Kenny and Carmack roads. The building, projected for a phased opening in 2023, will increase OSUCCC – James clinical operations space by 26.4% with the addition of a 44-bed outpatient surgery center, including interventional radiology services, a diagnostic imaging center, a retail pharmacy, radiation oncology, infusion services, and hematology and genitourinary clinics. The building also will contain the region’s first proton therapy treatment facility, offering treatment for adult and pediatric cancer patients in a single location. Proton therapy uses protons (highly charged particles) instead of X-rays to kill cancer cells. A highly targeted form of proton therapy known as FLASH will be investigated in clinical trials as part of the proton therapy center. Read More
Ohio State and IntraOp Announce Collaboration in Flash Radiotherapy
In the summer of 2020, IntraOp Medical Corporation delivered its preclinical, high-dose-rate electron beam linear accelerator to the OSUCCC – James for the study of FLASH radiotherapy. The system was purchased by the OSUCCC – James and is the first IntraOp FLASH system delivered to a U.S institution with confirmed capabilities of delivering dose rates of over 600 Gy per second in 6 and 9 MeV. Preclinical testing has demonstrated that FLASH radiotherapy has several biological benefits and an improved therapeutic index by producing a protective effect for normal tissue. This technology, a highly targeted form of proton therapy, represents a paradigm shift in oncology and has the potential to expand and improve the role of radiation therapy for patients with cancer. Read More
Academic Agreement Establishes Pathology Collaboration With Japanese Medical Center
An academic agreement between The Ohio State University and Kameda Medical Center in Japan will enable these institutions to share different perspectives on medical care and provide international experience for residents and fellows in their respective pathology departments. The university entered the academic memorandum of understanding (MOU) in August 2020 to facilitate educational and cultural exchange with Kameda Medical Center on behalf of Ohio State’s College of Medicine, Department of Pathology and the OSUCCC – James. The academic MOU follows a clinical MOU between Ohio State and Kameda that was signed in February 2020. The clinical MOU, which enables Ohio State to provide pathology consultation services to Kameda for patients in Japan, is valid for two years with an option for renewal. The newer academic MOU has no end date. Read More
Acute Leukemia Program Gains Prestigious Quality Designation From Joint Commission
The OSUCCC – James Acute Leukemia Program earned a disease-specific care certification in leukemia from The Joint Commission, the nation’s top hospital-ranking organization. The OSUCCC – James Acute Leukemia Program is the third program in the United States to earn this advanced-level certification, validating the dedication and commitment of the doctors, nurses and staff at the OSUCCC – James. Read More
OSUCCC – James Achieves Comprehensive Center of Excellence Designation for Lymphatic Disease Treatment
The OSUCCC – James was designated a Comprehensive Center of Excellence in the Diagnosis and Treatment of Lymphatic Diseases by the Lymphatic Education and Research Network (LE&RN). This designation is given to hospitals that meet stringent quality standards for medical care of lymphedema and lymphatic diseases (LD) in patient communities, including oncology. The OSUCCC – James was one of 11 hospitals nationwide and the only hospital in Ohio to achieve this quality designation. The Lymphatic Education and Research Network (LE&RN) is a nonprofit organization founded in 1998 to fight LD and lymphedema through education, research and advocacy. Read More
Ohio State Colleges Receive Award for Excellence in Diversity
Ohio State’s colleges of Medicine, Nursing, Optometry and Veterinary Medicine were honored with the 2020 Health Professions Higher Education Excellence in Diversity (HEED) Award by INSIGHT Into Diversity magazine, the oldest and largest diversity-focused publication in higher education. This is the second consecutive year that four health science colleges at Ohio State have earned this honor, and the fifth year for the College of Nursing. Ohio State is the only academic institution in the country to have four colleges receive this 2020 designation. Read More
Despite Pandemic, Pelotonia 2020 Raises Over $10.5 Million for Cancer Research at Ohio State
Participants, donors and volunteers in Pelotonia 2020 raised $10,502,362 for cancer research at the OSUCCC – James and boosted the 12-year total for this annual cycling event to $217,525,912 — every dollar of which goes to research thanks to Pelotonia’s major funding partners. Because the COVID-19 pandemic prevented the traditional weekend mass cycling ride in August, Pelotonia was redefined through a My Pelotonia platform that allowed participants of all ages to choose their own goals for raising money for cancer research. Pelotonia 2020 drew 11,274 participants from 47 U.S. states and seven countries who rose to the challenge in individualized or small-group outings and feats, including 822,362 miles logged via cycling, running, hiking or kayaking. Volunteers also contributed 4,715 hours to the cause. Read More